Subscribe to MDT Magazine News

Recalled DePuy ASR Hip Implant Lawsuits Filed By John David Hart

May 20, 2011 8:39 am | by Bio-Medicine.Org | Comments

FORT WORTH, Texas, May 20, 2011 /- Eight cases were filed yesterday by the Law Offices of John David Hart on behalf of plaintiffs whose DePuy ASR Acetabular Hip Replacement Systems have been recalled.  The cases were filed on behalf of Linda Sue and Richard Hall, Holt and Suzanne...


Omron Healthcare Announces Donation to the American Society of Hypertension, Inc.

May 20, 2011 8:37 am | by Bio-Medicine.Org | Comments

BANNOCKBURN, Ill., May 20, 2011 /- Omron Healthcare, Inc., the number one brand recommended by doctors in the home blood pressure category, announced today its donation of 300 blood pressure monitors worth more than $30,000 to the American Society of Hypertension (ASH). The donation will...


Lee W. Wattenberg, M.D., Receives the 2011 AACR Award for Lifetime Achievement in Cancer Prevention Research

May 20, 2011 7:40 am | by AACR | Comments

Tweet PHILADELPHIA - Lee W. Wattenberg, M.D., will receive the 2011 AACR Award for Lifetime Achievement in Cancer Prevention Research for his role in launching the field of chemoprevention and his work to understand the potential mechanisms of action of chemopreventive compounds....


Consumer Information on: Abbott RealTime HCV - P100017

May 20, 2011 7:34 am | by U.S. Food & Drug Administration | Comments

The Abbott RealTime HCV assay is a laboratory test that measures the amount of hepatitis C viral RNA in the blood of an individual infected with the hepatitis C virus (HCV).


Summary Information for: Abbott RealTime HCV

May 20, 2011 7:34 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Abbott RealTime HCV (P100017).


Report Warns of Strain on U.S. Cities to Maintain Assets & Build Infrastructure Projects

May 20, 2011 6:43 am | by Material Handling Industry of America | Comments

The United States will need to invest $2 trillion in the coming years to upgrade roads, bridges and other related infrastructure necessities in a country that is falling behind the rest of the world with its aging transportation system, according to a

BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow

May 20, 2011 6:41 am | by Bio-Medicine.Org | Comments

SAN JOSE, Calif., May 20, 2011 /- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), launched today the BD FACSVerse™ Flow Cytometer, a flexible, reliable and scalable system that can analyze up to 10 parameters and support a wide range of research...


Rudolph's 3D package inspection system meets TSV, RDL, bump inspection needs

May 20, 2011 5:52 am | by I-Micronews | Comments

Rudolph Technologies, Inc. (NASDAQ: RTEC), process characterization equipment and software provider to wafer fabs and advanced packaging facilities, released the Wafer Scanner 3880 inspection and measurement system for advanced packaging applications.


Firouz resigned weeks ago as EMD Serono head

May 20, 2011 5:51 am | by Mass High Tech: The Journal of New England Technology | Comments

The president and CEO of Rockland-based EMD Serono Inc., Fereydoun Firouz, resigned at the beginning of May, the company is now reporting. Chief commercial officer James Hoyes is now serving as acting head of the company, which is a subsidiary of Germany's Merck KGaA.

Brio Device Awarded Best of Ann Arbor SPARK's Boot Camp

May 20, 2011 5:45 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., May 20, 2011 /- Ann Arbor SPARK recently celebrated the conclusion of its 19th Boot Camp program with participant investor pitches and a reception.  At the Ann Arbor SPARK Boot Camp Celebration, Brio Device, LLC was selected as the "Best of Boot Camp" winner, based...


Gumz to Retire as President and CEO of Olympus Corporation of the Americas

May 20, 2011 5:45 am | by Bio-Medicine.Org | Comments

CENTER VALLEY, Pa., May 20, 2011 /- Olympus Corporation of the Americas (OCA) today announced that F. Mark Gumz, President and Chief Executive Officer, will retire from the company effective May 31. Karl Watanabe, current OCA Executive Vice President and Chief Financial Officer, will be...


Paralyzed man freely moves after getting implant

May 20, 2011 5:45 am | by MARIA CHENG - AP Medical Writer - Associated Press | Comments

After Rob Summers was paralyzed below the chest in a car accident in 2006, his doctors told him he would never stand again. They were wrong.Despite intensive physical therapy for three years, Summers' condition hadn't improved. So in 2009, doctors implanted an electrical stimulator onto the...

ImmunoGen expects $84 M in stock offering proceeds

May 20, 2011 5:45 am | by The Associated Press | Comments

ImmunoGen Inc. expects to generate about $84 million in gross proceeds from an offering of 7 million shares, the cancer treatment developer said Friday.The Waltham, Mass., company priced the offering at $12 per share. The offering is expected to close Wednesday, and ImmunoGen has granted...

Gen-Probe Files for US Regulatory Clearance of PANTHERâ„¢ System, Fully Automated and Integrated Molecular Testing Instrument

May 20, 2011 5:41 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 20, 2011 /- Gen-Probe Incorporated (NASDAQ: GPRO ) announced today that the Company has filed a 510(k) application with the US Food and Drug Administration for its PANTHER™ system, a fully automated and integrated molecular testing system designed with the flexibility...


Amgen Receives CHMP Positive Opinion for XGEVAâ„¢ (Denosumab) in the European Union

May 20, 2011 5:41 am | by Bio-Medicine.Org | Comments

THOUSAND OAKS, Calif., May 20, 2011 /- Amgen (Nasdaq: AMGN ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended a positive opinion for the marketing authorization of XGEVA™ (denosumab) for the...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.